These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Presternal atheroma and its surgical treatment]. Groenendijk-Huijbers MM Ned Tijdschr Geneeskd; 1994 Nov; 138(47):2368. PubMed ID: 7526226 [No Abstract] [Full Text] [Related]
6. A heparinoid-hyaluronidase ointment in the treatment of chronic leg ulcers. Jefferson J; McKnight AG Practitioner; 1967 Mar; 198(185):402-5. PubMed ID: 4166910 [No Abstract] [Full Text] [Related]
7. [Experience with a new preparation for the treatment of hemorrhoids]. Bottero G; Slaviero G Minerva Med; 1972 Jun; 63(43):2431-7. PubMed ID: 4113734 [No Abstract] [Full Text] [Related]
8. [Long-term use of D-penicillamine in systemic scleroderma and rheumatoid arthritis]. Guseva NG; Trofimova TM; Oskilko TG; Panasiuk AF; Tarasenkova TA Klin Med (Mosk); 1986 Jun; 64(6):44-50. PubMed ID: 3747436 [No Abstract] [Full Text] [Related]
9. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma]. Didenko IG Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249 [No Abstract] [Full Text] [Related]
11. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique. Høyer H; Hvid-Jacobsen K; Weismann K Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898 [TBL] [Abstract][Full Text] [Related]
12. Treatment of generalized scleroderma with inhibitors of connective tissue formation. Asboe-Hansen G Acta Derm Venereol; 1975; 55(6):461-5. PubMed ID: 55038 [TBL] [Abstract][Full Text] [Related]
13. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma]. Alekperov RT; Avdeev SN; Kotovskaia MA Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466 [No Abstract] [Full Text] [Related]
14. Progressive systemic sclerosis and penicillamine. Rodnan GP J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873 [TBL] [Abstract][Full Text] [Related]
15. [The clinical picture and therapy of progressive systemic scleroderma]. Sönnichsen N; Brenke A; Witt C Dtsch Med Wochenschr; 1992 Mar; 117(11):427-31. PubMed ID: 1544345 [No Abstract] [Full Text] [Related]
16. [Treatment of interstitial pulmonary fibrosis with D-penicillamine in progressive scleroderma: a long-term study (author's transl)]. Bröll H; Tausch G; Eberl R Wien Klin Wochenschr; 1976 Apr; 88(9):292-5. PubMed ID: 973388 [TBL] [Abstract][Full Text] [Related]
17. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects. Shapiro LS; Prince RK; Buckingham RB; Rodnan GP J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687 [TBL] [Abstract][Full Text] [Related]
18. [Theoretical aspects of the new possibilities of use of hyaluronidase]. Petter O; Bellmann H Z Gesamte Inn Med; 1971 Mar; 26(5):171-4. PubMed ID: 5560774 [No Abstract] [Full Text] [Related]
19. [Therapy of progressive scleroderma. Collagen-like protein in progressive scleroderma under D-penicillamine therapy]. Kreysel HW; Schlichting H; Kimmig J Fortschr Med; 1975 Nov; 93(32):1596-9. PubMed ID: 1220999 [TBL] [Abstract][Full Text] [Related]
20. Predictors and outcomes of scleroderma renal crisis: data from the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Strand V Arthritis Rheum; 2002 Nov; 46(11):2836-7. PubMed ID: 12428222 [No Abstract] [Full Text] [Related] [Next] [New Search]